Incidence and mitigation of gastrointestinal events in patients with relapsing–remitting multiple sclerosis receiving delayed-release dimethyl fumarate: a German phase IV study (TOLERATE)

BACKGROUND: Gastrointestinal (GI) events are common adverse events (AEs) associated with delayed-release dimethyl fumarate (DMF), an approved treatment for relapsing–remitting multiple sclerosis (RRMS). The objective of the TOLERATE study was to evaluate GI tolerability and GI mitigation via symptom...

Descripción completa

Detalles Bibliográficos
Autores principales: Gold, Ralf, Schlegel, Eugen, Elias-Hamp, Birte, Albert, Christian, Schmidt, Stephan, Tackenberg, Björn, Xiao, James, Schaak, Tom, Salmen, Hans Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5912264/
https://www.ncbi.nlm.nih.gov/pubmed/29707040
http://dx.doi.org/10.1177/1756286418768775

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5912264/
https://www.ncbi.nlm.nih.gov/pubmed/29707040
http://dx.doi.org/10.1177/1756286418768775

Ejemplares similares